MARKET

IQV

IQV

IQVIA Holdings
NYSE

Real-time Quotes | Nasdaq Last Sale

242.32
-5.02
-2.03%
After Hours: 242.32 0 0.00% 16:25 01/18 EST
OPEN
243.18
PREV CLOSE
247.34
HIGH
245.58
LOW
240.51
VOLUME
846.16K
TURNOVER
--
52 WEEK HIGH
285.61
52 WEEK LOW
170.00
MARKET CAP
46.43B
P/E (TTM)
61.64
1D
5D
1M
3M
1Y
5Y
Cooper Investors Remains Optimistic in IQVIA Holdings (IQV)
Cooper Investors, an investment management firm, published its “Cooper Investors Global Equities Fund (Hedged)” fourth quarter 2021 investor letter – a copy of which can be downloaded here. For the 3 months and 12 months to December 31st, the Fund returned...
Insider Monkey · 15h ago
Vaughan Nelson Investment Management, L.p. ...
Houston, TX, based Investment company Vaughan Nelson Investment Management, L.p. (Current Portfolio) buys Berkshire Hathaway Inc, Vertex Pharmaceuticals Inc, Ballys Corp, Beacon Roofing Supply Inc, Performance Food Group Co, sells Mastercard Inc, Moderna I...
GuruFocus.com · 5d ago
First American Trust, Fsb Buys Nike Inc, Tesla Inc, Teradyne Inc, Sells Starbucks Corp, Newmont ...
Investment company First American Trust, Fsb (Current Portfolio) buys Nike Inc, Tesla Inc, Teradyne Inc, Union Pacific Corp, Uber Technologies Inc, sells Starbucks Corp, Newmont Corp, Walmart Inc, Activision Blizzard Inc, Stericycle Inc during the 3-months...
GuruFocus.com · 01/11 18:38
IQVIA Holdings (IQV) Stock Up 34.4% In a Year: Here's Why
Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.
Zacks · 01/11 17:30
What Type Of Shareholders Make Up IQVIA Holdings Inc.'s (NYSE:IQV) Share Registry?
If you want to know who really controls IQVIA Holdings Inc. ( NYSE:IQV ), then you'll have to look at the makeup of its...
Simply Wall St. · 01/05 10:51
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
Zacks.com · 01/04 00:30
Paychex (PAYX) Q2 Earnings & Revenues Beat, 2022 View Up
Zacks.com · 01/02 00:25
Paychex (PAYX) Set to Report Q2 Earnings: What to Expect?
Zacks.com · 01/02 00:25
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IQV. Analyze the recent business situations of IQVIA Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

38.10%Strong Buy
57.14%Buy
4.76%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average IQV stock price target is 303.83 with a high estimate of 350.00 and a low estimate of 261.00.
High350.00
Average303.83
Low261.00
Current 242.32
EPS
Actual
Estimate
0.611.221.822.43
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 957
Institutional Holdings: 172.84M
% Owned: 90.20%
Shares Outstanding: 191.61M
TypeInstitutionsShares
Increased
338
6.67M
New
64
552.57K
Decreased
312
7.61M
Sold Out
41
1.51M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-4.74%
Pharmaceuticals & Medical Research
-1.37%
Key Executives
Chairman/President/Chief Executive Officer/Director
Ari Bousbib
Chief Financial Officer/Executive Vice President
Ronald Bruehlman
Corporate Executive
Kevin Knightly
Corporate Executive
Walter Staub
Executive Vice President/General Counsel/Secretary
Eric Sherbet
Lead Director/Independent Director
John Leonard
Independent Director
Carol Burt
Independent Director
John Connaughton
Independent Director
John Danhakl
Independent Director
James Fasano
Independent Director
Colleen Goggins
Independent Director
Ronald Rittenmeyer
Independent Director
Todd Sisitsky
No Data
About IQV
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.

Webull offers kinds of Iqvia Holdings Inc stock information, including NYSE:IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.